Genetic Counseling and Partner Screening
At a Glance
Men with CBAVD are almost always carriers of CFTR gene mutations. Before starting fertility treatments, your partner must undergo extended genetic screening. If both partners are carriers, IVF with Preimplantation Genetic Testing (PGT-M) can ensure you have a healthy child without Cystic Fibrosis.
Before proceeding with fertility treatments, there is one step that is widely considered the most critical in your entire journey: Genetic Counseling and Partner Screening [1][2].
Because CBAVD is so closely tied to the CFTR gene, your diagnosis has implications that reach beyond your own health and directly impact the health of your future children [3].
Why Partner Screening is the Standard of Care
Men with CBAVD are almost always carriers of at least one (and often two) CFTR mutations [4]. While your mutations are likely “mild” enough that they only affected your vas deferens, they can still be passed on to your children [2].
The goal of screening your partner is to determine if she is also a carrier of a CFTR mutation [5]. About 1 in every 25 to 30 people of Northern European descent are silent carriers of a CFTR mutation without knowing it (though this carrier rate varies significantly by ethnic background) [2]. If she is a carrier, the combination of your mutations and hers could lead to a child with classic Cystic Fibrosis (CF)—a serious, life-long condition affecting the lungs and digestion [3][6].
It is highly recommended that she undergoes an extended CFTR panel that specifically looks for “mild” variants like the 5T allele—not just a standard, basic CF carrier screen [1].
Understanding the Risk Scenarios
A genetic counselor will help you map out the specific risks based on your DNA results. The risk depends entirely on the “dose” of mutations the child receives:
- Partner is NOT a carrier: The risk of having a child with classic CF is extremely low. Furthermore, because CFTR conditions require a mutation from both parents, any sons you have will simply be healthy carriers like your partner; they will not have CF and they will not have CBAVD [2].
- Partner IS a carrier: This is the high-risk scenario. If your partner also carries a mutation, there is a significant chance (up to 25% or 50%, depending on your specific genetics) that your child could inherit two mutations and be born with classic Cystic Fibrosis [4][2].
Your Options: Preimplantation Genetic Testing (PGT)
If both you and your partner are found to be carriers, you do not have to leave the health of your child to chance. Modern medicine offers a way to screen for these mutations before a pregnancy even begins [7].
This process is called Preimplantation Genetic Testing for Monogenic Disorders (PGT-M):
- The Process: During an IVF cycle, your embryos are grown in a lab for a few days.
- The Test: A few cells are carefully removed from each embryo and tested specifically for the CFTR mutations identified in you and your partner [7].
- The Selection: Only embryos that do not have the high-risk combination of mutations are selected for transfer into the uterus [8][9].
Important Expectations: Developing the custom genetic “probes” to test your embryos can add weeks or even months to your IVF timeline, and the testing itself carries additional financial costs. However, couples who use PGT-M have very high success rates, and the clinical outcomes for these pregnancies are generally excellent, comparable to standard IVF [8][10].
The Role of the Genetic Counselor
A genetic counselor is a specialist who helps you navigate these complex choices. They don’t just look at lab results; they help you understand the technical details, manage the emotional weight of the diagnosis, and coordinate the specialized testing needed for your embryos [11][12].
Meeting with a counselor is not just a “box to check”—it is the foundation for ensuring you can build your family with confidence and peace of mind [13].
Common questions in this guide
Does having CBAVD mean I am definitely a carrier of a CFTR mutation?
Why does my partner need genetic testing if I am the one with CBAVD?
What kind of genetic test does my female partner need?
What happens if both my partner and I are CFTR mutation carriers?
How does preimplantation genetic testing (PGT-M) work?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Since I have CBAVD, does that mean I am definitely a carrier of a CFTR mutation, even if my first test was negative?
- 2.If we both have mutations, what are the odds of our child having classic Cystic Fibrosis versus CBAVD or being a healthy carrier?
- 3.Does my partner need 'full gene sequencing' or just a 'standard carrier panel'?
- 4.How does PGT-M work in the lab, and what is the success rate for selecting healthy embryos in your clinic?
- 5.Can you refer us to a genetic counselor who specializes in male factor infertility and CFTR mutations?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (13)
- 1
Genetics of CFTR and male infertility.
Bieniek JM, Lapin CD, Jarvi KA
Translational andrology and urology 2021; (10(3)):1391-1400 doi:10.21037/tau.2020.04.05.
PMID: 33850775 - 2
Congenital Bilateral Absence of the Vas Deferens.
Cai Z, Li H
Frontiers in genetics 2022; (13()):775123 doi:10.3389/fgene.2022.775123.
PMID: 35222530 - 3
Congenital bilateral absence of the vas deferens as an atypical form of cystic fibrosis: reproductive implications and genetic counseling.
de Souza DAS, Faucz FR, Pereira-Ferrari L, et al.
Andrology 2018; (6(1)):127-135 doi:10.1111/andr.12450.
PMID: 29216686 - 4
Prevalence of CBAVD in azoospermic men carrying pathogenic CFTR mutations - Evaluated in a cohort of 639 non-vasectomized azoospermic men.
Fedder J, Jørgensen MW, Engvad B
Andrology 2021; (9(2)):588-598 doi:10.1111/andr.12925.
PMID: 33095972 - 5
Cystic fibrosis transmembrane conductance regulator (CFTR) gene abnormalities in Indian males with congenital bilateral absence of vas deferens & renal anomalies.
Gajbhiye R, Kadam K, Khole A, et al.
The Indian journal of medical research 2016; (143(5)):616-23 doi:10.4103/0971-5916.187110.
PMID: 27488005 - 6
Mutations of the cystic fibrosis transmembrane conductance regulator gene in males with congenital bilateral absence of the vas deferens: Reproductive implications and genetic counseling (Review).
Cui X, Wu X, Li Q, Jing X
Molecular medicine reports 2020; (22(5)):3587-3596 doi:10.3892/mmr.2020.11456.
PMID: 33000223 - 7
Preventing transmission of dyschromatosis universalis hereditaria through preimplantation genetic testing: A case report.
Wang XL, Zou T, Wu YC, et al.
World journal of clinical cases 2025; (13(31)):110620 doi:10.12998/wjcc.v13.i31.110620.
PMID: 41283180 - 8
IVF success rates in individuals accessing preimplantation genetic testing for monogenic conditions (PGT-M): a single centre retrospective cohort study of 572 IVF cycles.
Poulton A, Menezes M, Hardy T, et al.
Journal of assisted reproduction and genetics 2025; (42(5)):1567-1576 doi:10.1007/s10815-025-03416-6.
PMID: 40067642 - 9
The improvement of the best practice guidelines for preimplantation genetic diagnosis of cystic fibrosis: toward an international consensus.
Girardet A, Viart V, Plaza S, et al.
European journal of human genetics : EJHG 2016; (24(4)):469-78 doi:10.1038/ejhg.2015.99.
PMID: 26014425 - 10
Clinical outcomes following preimplantation genetic testing for monogenic conditions: a systematic review of observational studies.
Poulton A, Menezes M, Hardy T, et al.
American journal of obstetrics and gynecology 2025; (232(2)):150-163 doi:10.1016/j.ajog.2024.09.114.
PMID: 39362513 - 11
Use of preimplantation genetic testing for monogenic adult-onset conditions: an Ethics Committee opinion.
Fertility and sterility 2024; (122(4)):607-611 doi:10.1016/j.fertnstert.2024.05.165.
PMID: 38944787 - 12
Use of preimplantation genetic testing for monogenic defects (PGT-M) for adult-onset conditions: an Ethics Committee opinion.
,
Fertility and sterility 2018; (109(6)):989-992 doi:10.1016/j.fertnstert.2018.04.003.
PMID: 29935659 - 13
Utilization of preimplantation genetic testing for monogenic disorders.
Lee I, Alur-Gupta S, Gallop R, Dokras A
Fertility and sterility 2020; (114(4)):854-860 doi:10.1016/j.fertnstert.2020.05.045.
PMID: 33040985
This page explains the role of genetic counseling and CFTR testing in CBAVD for educational purposes only. Always consult a certified genetic counselor or fertility specialist regarding your specific genetic risks and family planning options.
Get notified when new evidence is published on Congenital bilateral absence of vas deferens.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.